HK1162526A1 - 衍生物及其應用 - Google Patents

衍生物及其應用

Info

Publication number
HK1162526A1
HK1162526A1 HK12102651.2A HK12102651A HK1162526A1 HK 1162526 A1 HK1162526 A1 HK 1162526A1 HK 12102651 A HK12102651 A HK 12102651A HK 1162526 A1 HK1162526 A1 HK 1162526A1
Authority
HK
Hong Kong
Prior art keywords
glp
derivatives
Prior art date
Application number
HK12102651.2A
Other languages
English (en)
Inventor
譚芬來王印祥丁列明王燕萍馬存波李彩娜胡云雁曹紅胡邵京龍偉韓斌
Original Assignee
貝達藥業股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 貝達藥業股份有限公司 filed Critical 貝達藥業股份有限公司
Publication of HK1162526A1 publication Critical patent/HK1162526A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/605—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Child & Adolescent Psychology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
HK12102651.2A 2010-08-06 2012-03-16 衍生物及其應用 HK1162526A1 (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201010246866 2010-08-06
CN201110078528 2011-03-30
PCT/CN2011/000765 WO2012016419A1 (zh) 2010-08-06 2011-04-29 Glp-1衍生物及其应用

Publications (1)

Publication Number Publication Date
HK1162526A1 true HK1162526A1 (zh) 2012-08-31

Family

ID=45558923

Family Applications (1)

Application Number Title Priority Date Filing Date
HK12102651.2A HK1162526A1 (zh) 2010-08-06 2012-03-16 衍生物及其應用

Country Status (2)

Country Link
HK (1) HK1162526A1 (zh)
WO (1) WO2012016419A1 (zh)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9764003B2 (en) 2012-07-01 2017-09-19 Novo Nordisk A/S Use of long-acting GLP-1 peptides
CA3078652A1 (en) 2017-10-12 2019-04-18 Novo Nordisk A/S Semaglutide in medical therapy
RS63523B1 (sr) 2018-04-05 2022-09-30 Sun Pharmaceutical Ind Ltd Novi glp-1 analozi

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MA24129A1 (fr) * 1996-08-30 1997-10-01 Novozymes As Procede pour deformer une matiere textile cellulosique
TWI362392B (en) * 2005-03-18 2012-04-21 Novo Nordisk As Acylated glp-1 compounds
CA2596926A1 (en) * 2005-03-18 2006-09-21 Novo Nordisk A/S Extended glp-1 compounds

Also Published As

Publication number Publication date
WO2012016419A1 (zh) 2012-02-09

Similar Documents

Publication Publication Date Title
HUS2100032I1 (hu) Helyettesített 5-fluor-1H-pirazolopiridin-származékok és alkalmazásuk
HK1206004A1 (zh) 巨大戟二萜醇- -酰化物 和巨大戟二萜醇- -氨基甲酸酯
HK1187049A1 (zh) 雙芳基連接的芳基三唑酮及其用途
EP2552953A4 (en) FRIZZLED-BINDING SUBSTANCES AND ITS USES
ZA201208173B (en) Peptices and their use
HRP20160922T1 (hr) Oligopeptidni spojevi i njihove uporabe
ZA201303773B (en) Compounds and their use
HRP20182083T1 (hr) Nova kombinacija i uporaba
EP2575453A4 (en) OLIGO-BENZAMIDE COMPOUNDS AND THEIR USE
EP2608785A4 (en) LIPOMA CYCLES AND ITS USES
EP2529013A4 (en) NOVEL BETA GLUCOSIDASE AND USES THEREOF
EP2615094A4 (en) SESTERTERPEN COMPOUNDS AND THEIR USE
HK1162526A1 (zh) 衍生物及其應用
EP2638160A4 (en) NUCLIONS AND RIBOCAPSIDES
GB201014319D0 (en) Compounds and uses thereof
GB201020848D0 (en) Compounds and their use
GB201018028D0 (en) Compounds and their use
GB201017822D0 (en) Compounds and their use
GB201005511D0 (en) Compounds and their use
GB201002337D0 (en) Compounds and their use
GB201000309D0 (en) Compounds and their use
GB201000305D0 (en) Compounds and their use
GB201000307D0 (en) Compounds and their use
GB201000308D0 (en) Compounds and their use

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20230501